-
Product Insights
Iron Deficiency Anemia – Drugs In Development, 2023
Global Markets Direct’s, ‘Iron Deficiency Anemia - Drugs In Development, 2023’, provides an overview of the Iron Deficiency Anemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Iron Deficiency Anemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Iron Deficiency Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Anemia is a condition in which the body does not have enough healthy red blood cells. Iron helps make red blood cells. When the body does not have enough iron, it will make fewer red blood cells or red blood cells that are too small. This is called iron deficiency anemia. Symptoms include feeling grumpy, headaches, and problems concentrating or thinking. Treatment includes iron supplements and eating iron-rich foods. The Iron Deficiency Anemia drugs in development market research report provide...
-
Product Insights
Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2017" provides an overview of Chemotherapy Induced Anemia clinical trials scenario. This report provides top line data relating to the clinical trials on Chemotherapy Induced Anemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Iron Deficiency Anemia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Iron Deficiency Anemia Global Clinical Trials Review, H2, 2017" provides an overview of Iron Deficiency Anemia clinical trials scenario. This report provides top line data relating to the clinical trials on Iron Deficiency Anemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
Competitor Landscape: Renal Anemia
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Renal Anemia market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Product Insights
Chemotherapy Induced Anemia Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Chemotherapy Induced Anemia Global Clinical Trials Review, H2, 2018" provides an overview of Chemotherapy Induced Anemia clinical trials scenario. This report provides top line data relating to the clinical trials on Chemotherapy Induced Anemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2016" provides an overview of Chemotherapy Induced Anemia clinical trials scenario. This report provides top line data relating to the clinical trials on Chemotherapy Induced Anemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...